Liquid Biopsy 2020

Conference: February 20th - 21th, 2020 (Lisbon, Portugal)

The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. 

This year’s event will bring together the leaders in the field from pharma, biotech, Dx companies and healthcare and be the home of multi-stakeholder and pan-industry collaboration for liquid biopsy, molecular pathology and precision medicine experts to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as application of liquid biopsy testing, across biofluids, biomarkers and disease indications, as the needle shifts on the gold standard of personalized healthcare testing.

The field of liquid biopsy is moving beyond isolation and characterization of CTCs and ctDNA to surveillance, early detection of relapse and minimal residual disease, and interventional studies in clinical applications. The scope of the conference encompasses circulating tumor cells, cell-free circulating DNA, exosomes and extracellular vesicles. This meeting has become an important annual event for leaders in the community to discuss the tools, validation and implementation of circulating biomarkers, which are transforming our understanding and management of disease.

The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

Key practical points 

  • Liquid Biopsy: New Opportunities, Technologies, and Challenges in the Field
  • Clinical integration of liquid biopsy
  • Circulating Tumor Cells: History and Future Perspectives
  • Improving the Quality of Circulating Tumor DNA Measurements
  • Circulating Tumor Cells in Monitoring Cancer
  • Extracellular vesicles (Evs)
  • New Tools for Liquid Biopsies: Microfluidic Platforms for the Isolation of CTCs, cfDNA and Exosomes
  • CTC Isolation Platforms and Using CTCs for Monitoring Therapy Responses
  • Dissecting Mechanisms of Breast Cancer Metastasis Using Patient Derived Circulating Tumor Cells
  • Liquid Biopsies in Cancer Immunotherapy Clinical Drug Development
  • Heterogeneity of Cancer-Derived Extracellular Vesicles
  • Liquid Biopsies in Oncology and the Current Regulatory Landscape
  • Validating Liquid Biopsies in Cancer
  • ctDNA Liquid Biopsy Assay

Who should attend

The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

  • Liquid biopsy
  • Clinical Pathology
  • Molecular Assay Development
  • Medical Laboratory
  • Scientific Affairs
  • Sales and Marketing
  • Quality Management
  • Process Development
  • Commercial & Outreach, Oncology
  • Molecular pathology
  • Research Scientist
  • Molecular Biology
  • Sales & Business Development
  • Clinical and Translational Affairs
  • Clinical Research
  • Companion Diagnostics
  • Biomarkers
  • Manufacturing
  • Scientific Affairs
  • Clinical Trial
  • Oncology Business Development
  • Precision medicine
  • Clinical Laboratory
  • Immunochemistry
  • Cell Culture
  • Clinical Genomics

For details and to register, visit the website at https://biotechpharmasummit.com/index.php/event/liquid-biopsy-2020/

Featured Events


 bio150
DISRUPTIVE TECHNOLOGIES IN PHARMA 150x150 copy
6th International Conference on Food and Beverages 150x150
resizeimaged images
Banner Liquid Biopsy Lisbon February 2020 150
Banner Gut Week 2020 150
150Nano Pharma 2020
LS169 Farmavita 150